Marco Roffi

Q: What Schools Are Affiliated With Marco Roffi

Marco Roffi is affiliated with the following schools: University of Milan, United States Military Academy, University of Bern, University of Geneva

Marco Roffi's AcademicInfluence.com Rankings

Marco Roffi

Computer Science

#6567

World Rank

#6924

Historical Rank

Machine Learning

#2177

World Rank

#2205

Historical Rank

Artificial Intelligence

#2443

World Rank

#2484

Historical Rank

Database

#3650

World Rank

#3801

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Marco Roffi's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Marco Roffi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marco Roffi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). (2018) (6316)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). (2011) (5496)
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. (2016) (2910)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2020) (2041)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. (2020) (1960)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. (2018) (1802)
[2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. (2014) (1716)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b (2018) (1641)
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases (2012) (1546)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases (2015) (1182)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (983)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] (2018) (913)
2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (880)
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (811)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) (738)
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] (2018) (669)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. (2005) (607)
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. (2016) (603)
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. (2001) (470)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes (2001) (429)
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. (2015) (327)
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. (2002) (316)
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. (2012) (311)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2020) (310)
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. (2015) (300)
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein (2005) (267)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (267)
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. (2015) (248)
[2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)] (2017) (235)
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial (2014) (230)
Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials (2002) (223)
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. (2007) (183)
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. (2015) (170)
Randomized Comparison of a Titanium-Nitride-Oxide–Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TiNOX Trial (2005) (168)
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. (2002) (152)
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. (2001) (149)
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. the swiss heart study: a randomized controlled trial☆ (2003) (146)
Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. (2011) (135)
Local versus general anesthesia for transcatheter aortic valve implantation (TAVR) – systematic review and meta-analysis (2014) (135)
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial. (2016) (129)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (128)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic (2020) (125)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017) (124)
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. (2021) (124)
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial (2019) (110)
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. (2004) (110)
Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. (2001) (107)
Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up (2002) (103)
Current concepts on coronary revascularization in diabetic patients. (2011) (99)
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). (2005) (95)
Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. (2010) (94)
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted Fro (2014) (94)
Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves (2015) (88)
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. (2007) (84)
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST (2017) (83)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) (2014) (83)
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial (2018) (81)
Carotid artery stenting versus surgery: adequate comparisons? (2010) (80)
Corrigendum to: 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. (2015) (77)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. (2002) (71)
Carotid artery stenting vs. endarterectomy. (2009) (65)
The Obstacle Course of Reperfusion for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic (2020) (64)
Plasma homocysteine levels and late outcome after coronary angioplasty. (2002) (62)
Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review. (2013) (60)
Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare-Metal Stents in Acute Myocardial Infarction: Two-Year Clinical Results of the COMFORTABLE AMI Trial (2014) (59)
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry (2019) (58)
Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica (2016) (58)
Percutaneous intervention for symptomatic vertebral artery stenosis using coronary stents. (2001) (56)
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. (2014) (55)
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. (2017) (52)
Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial (2016) (52)
Time-effectiveness, observer-dependence, and accuracy of measurements of left ventricular ejection fraction using 4-channel MDCT. (2004) (49)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
Carotid artery stenting: an update. (2015) (49)
Early exercise after coronary stenting is safe. (2003) (49)
Temporal Trends in Adoption and Outcomes of Transcatheter Aortic Valve Implantation: A Swisstavi Registry Analysis. (2018) (48)
Association of plasma homocysteine with the number of major coronary arteries severely narrowed. (2001) (48)
Questions and answers on coronary revascularization: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2016) (47)
Percutaneous Treatment for Pacemaker‐Associated Superior Vena Cava Syndrome (2002) (46)
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study (2019) (46)
Flow Impairment during Protected Carotid Artery Stenting: Impact of Filter Device Design (2008) (43)
Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study. (2019) (42)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland (2015) (41)
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. (2006) (39)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
Transcatheter aortic valve implantation in nonagenarians: effective and safe. (2013) (38)
The Obstacle Course of Reperfusion for STEMI in the COVID-19 Pandemics. (2020) (38)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2021) (38)
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. (2003) (38)
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels (2002) (37)
Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2020) (37)
Angioplasty and provisional stent treatment of common femoral artery lesions. (2013) (37)
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. (2021) (36)
Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey. (2020) (36)
Feasibility of simultaneous bilateral carotid artery stenting (2004) (36)
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. (2014) (36)
Endovascular treatment of carotid artery aneurysms with stent grafts. (2002) (34)
Effect of HomocysteineLowering HomocysteineLowering HomocysteineLowering Therapy With Folic Acid , Vitamin B 12 , and Vitamin B 6 on Clinical Outcome After Percutaneous Coronary Intervention The Swiss Heart Study : A Randomized Controlled Trial (2002) (33)
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. (2012) (33)
Endovascular Stroke Treatment Today (2011) (33)
Age-Related Variations in Takotsubo Syndrome. (2020) (31)
Repositionable Versus Balloon‐Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis (2016) (30)
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. (2018) (29)
Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas (2012) (29)
Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents. (2001) (28)
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. (2016) (28)
The hospital results and 1-year outcomes of transcatheter aortic valve-in-valve procedures and transcatheter aortic valve implantations in the native valves: the results from the Swiss-TAVI Registry. (2019) (28)
Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Prespecified Subgroup Analysis of the BIOSCIENCE Trial (2015) (27)
Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force (2018) (27)
Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. (2001) (26)
Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS) (2018) (26)
ESC Core Curriculum for the Cardiologist. (2020) (26)
Wytyczne ESC dotyczące rozpoznawania i leczenia chorób aorty w 2014 roku (2014) (26)
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry. (2020) (25)
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation. (2016) (25)
Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries. (2003) (25)
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. (2005) (25)
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). (2004) (24)
Thyrotoxicosis and the cardiovascular system: subtle but serious effects. (2003) (24)
Carotid brachytherapy for in‐stent restenosis (2003) (24)
Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up. (2009) (24)
Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? (2016) (24)
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease. (2018) (24)
AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study. (2013) (23)
The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial. (2014) (23)
Diabetes and acute coronary syndromes. (2009) (23)
Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: insights from a nationwide registry 1997–2010 (2013) (23)
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction. (2019) (23)
Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives (2017) (23)
Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland (2017) (23)
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy (2015) (23)
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model (2017) (22)
Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. (2016) (21)
Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. (2018) (21)
Sirolimus eluting stent: a new era in interventional cardiology? (2003) (21)
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study. (2013) (21)
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61 (2019) (20)
Management of patients with concomitant severe coronary and carotid artery disease: is there a perfect solution? (2007) (20)
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting (2021) (20)
Impact of the COVID-19 pandemic on acute coronary syndromes. (2020) (20)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
Current role of emboli protection devices in percutaneous coronary and vascular interventions. (2009) (19)
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial. (2021) (19)
Novel doppler assessment of intracoronary volumetric flow reserve: validation against PET in patients with or without flow-dependent vasodilation. (2005) (19)
Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry (2016) (19)
Fatal coronary sinus and aortic erosions following percutaneous transvenous mitral annuloplasty device. (2011) (19)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial. (2019) (18)
Endovascular treatment of Angio‐Seal™‐related limb ischemia—Primary results and long‐term follow‐up (2010) (18)
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. (2003) (18)
Management of Combined Severe Carotid and Coronary Artery Disease (2012) (18)
A Randomized Study of SheathLess vs Standard Guiding Catheters for Transradial Percutaneous Coronary Interventions. (2016) (18)
Severe bilateral carotid stenosis: the impact of ipsilateral stenting on Doppler-defined contralateral stenosis. (2004) (17)
Angiographic documented coronary arterial spasm in absence of critical coronary artery stenoses in a patient with variant angina episodes during exercise and dobutamine stress echocardiography (2000) (17)
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial. (2016) (17)
Interventional Cardiology in Switzerland during the Year 2007 (2010) (17)
Treatment–risk paradox in acute coronary syndromes (2018) (17)
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. (2019) (16)
Management of vascular complications following transcatheter aortic valve implantation. (2015) (16)
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial. (2014) (16)
Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral and Structural Heart Disease. (2010) (16)
Postpartal dissection of all coronary arteries in an in vitro-fertilized postmenopausal woman. (2009) (15)
Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report (2020) (14)
Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents (2019) (14)
Age-Related Outcomes After Transcatheter Aortic Valve Replacement: Insights From the SwissTAVI Registry. (2021) (14)
Meta-analysis of randomized trials of postconditioning in ST-elevation myocardial infarction. (2014) (14)
CardioPulse: What's new in the 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2016) (14)
Pharmacologic preconditioning therapy prior to atrial septal defect closure in patients at high risk for acute pulmonary edema. (2012) (14)
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries]. (2012) (14)
Thyrotoxicosis and the cardiovascular system. (2005) (14)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. (2020) (13)
Sirolimus-Eluting Stenting of the External Carotid Artery for the Treatment of Ocular Ischemia (2006) (13)
Transradial access for peripheral and cerebrovascular interventions. (2013) (13)
Intracoronary thrombus in a 26-year-old man. (2006) (13)
Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay (2016) (13)
Conduction disorders using the Evolut R prosthesis compared with the CoreValve: has anything changed? (2018) (12)
Occurrence and Impact of Time Delay to Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction (2017) (12)
Platelet Function Test Use for Patients with Coronary Artery Disease in the Early 2020s (2020) (12)
Prognostic value of early exercise testing after coronary stent implantation. (2008) (12)
Uaktualnione stanowisko ESC dotyczące stosowania podwójnej terapii przeciwpłytkowej w chorobie wieńcowej w 2017 roku, przygotowane we współpracy z EACTS (2017) (12)
Endovascular treatment of carotid artery aneurysms with covered stents. (2001) (12)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients with Diabetes Mellitus: a Treatment-Risk Paradox (2019) (12)
Retrograde aortic valve crossing of the corevalve prosthesis using the buddy balloon technique (2014) (12)
Percutaneous coronary intervention of the left main trunk in congenitally anomalous single coronary artery. (2001) (12)
Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions with the support of the European Board of Neuroin (2021) (11)
Angiojet rheolytic thrombectomy in massive pulmonary embolism: locally efficacious but systemically deleterious? (2010) (11)
Interventional cardiology in Switzerland during the year 2010 (2012) (11)
Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry (2015) (11)
Diabetes and acute coronary syndrome. (2010) (11)
Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study. (2017) (11)
Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role? (2008) (10)
Questions and answers on diagnosis and risk assessment: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†. (2020) (10)
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (2018) (10)
Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction: Results From a Multi‐Center Randomized Trial (2017) (10)
Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial. (2018) (10)
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study (2020) (10)
Current evidence for carotid endarterectomy and carotid artery stenting (2010) (10)
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab. (2002) (10)
Late tamponade secondary to aortic root perforation by BioSTAR septal closure device. (2011) (10)
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus (2011) (10)
Roadmap for cardiovascular education across the European Society of Cardiology: inspiring better knowledge and skills, now and for the future. (2019) (9)
Current concepts on the management of concomitant carotid and coronary disease. (2013) (9)
Current perspectives on coronary revascularization in the diabetic patient. (2007) (9)
Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue? (2017) (9)
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents. (2017) (9)
Failure to retrieve undeployed paclitaxel-eluting coronary stents. (2006) (9)
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. (2018) (8)
Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts (2018) (8)
Seguimiento a 30 días tras el implante percutáneo de válvula aórtica CoreValve Evolut R: estudio prospectivo de pacientes no seleccionados (2017) (8)
Current strategies with high-dose tirofiban (2007) (8)
Switzerland: coronary and structural heart interventions from 2010 to 2015. (2017) (8)
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. (2003) (7)
La fibrilación auricular de nueva aparición o preexistente en los síndromes coronarios agudos: dos fenómenos distintos con un pronóstico comparable (2019) (7)
Wytyczne ESC dotyczące rozpoznawania i leczenia chorób tętnic obwodowych w 2017 roku, przygotowane we współpracy z ESVS (2017) (7)
Coronary to pulmonary artery fistulas: an incidental finding with challenging therapeutic options. (2011) (7)
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease. (2019) (7)
Guidewires for lower extremity artery angioplasty: a review. (2015) (7)
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction: Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial. (2016) (7)
Wytyczne ESC dotyczace postepowania w ostrych zespolach wiencowych bez przetrwalego uniesienia odcinka ST w 2015 roku. (2015) (7)
Overcoming the Challenges of the Transfemoral Approach in Transcatheter Aortic Valve Implantation. (2013) (7)
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. (2012) (7)
Starting a carotid artery stenting program is safe (2008) (7)
Carotid Stenting (2006) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2021) (7)
Asymptomatic carotid artery stenosis: state of the art management. (2013) (7)
Management of Patients with Carotid Artery Stenosis (2008) (6)
Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†. (2016) (6)
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction (2018) (6)
Interventional cardiology in Switzerland during the years 2008 and 2009 (2010) (6)
CTO PCI in Patients With Diabetes Mellitus: Sweet Perspectives. (2017) (6)
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study. (2015) (6)
Symptomatic Carotid Artery Disease: Revascularization. (2017) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
History of carotid artery stenting. (2013) (6)
Platelet glycoprotein IIb/IIIa receptor inhibitors--end of an era? (2008) (6)
Left‐to‐right shunt reduction with intra‐aortic balloon pump in postmyocardial infarction ventricular septal defect (2013) (6)
Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary Syndrome. (2018) (6)
Wytyczne ESC dotyczące postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST w 2015 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST (2015) (6)
Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction (2020) (5)
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation (2022) (5)
Surgical or Transcatheter Aortic-Valve Replacement. (2017) (5)
CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS). (2016) (5)
Early invasive strategy in the diabetic patient with non-ST-segment elevation acute coronary syndromes (2005) (5)
Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment. (2020) (5)
AngioJet® rheolytic thrombectomy: a new treatment option in cases of massive pulmonary embolism (2013) (5)
Grupo de Trabajo Conjunto sobre cirugía no cardiaca: Evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA) (2014) (5)
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis. (2017) (5)
Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome (2021) (5)
Differential Effects of Newer-Generation Ultrathin-Strut Versus Thicker-Strut Drug-Eluting Stents in Chronic and Acute Coronary Syndromes. (2021) (5)
High-risk pulmonary embolism with impending paradoxical embolism successfully treated with percutaneous catheter-based thrombectomy (2011) (5)
Temporal trends in cardiovascular risk factors’ prevalence in patients with myocardial infarction (2020) (5)
Dramatic increase in 30-day mortality in diabetic patients with non-ST segment elevation acute coronary syndromes (2002) (5)
[Use of an explanted pacemaker connected to a regular screw-in lead for temporary pacing]. (2011) (4)
Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD) (2020) (4)
Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents (2012) (4)
Quantitative Flow Ratio to Predict Nontarget Vessel–Related Events at 5 Years in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Angiography‐Guided Revascularization (2021) (4)
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry (2020) (4)
Symptom Improvement and Cachexia Reversal in an 84‐Year‐Old Woman After Percutaneous Closure of Atrial Septal Defect (2015) (4)
Is there a role for revascularisation in asymptomatic carotid stenosis? Yes (2010) (4)
Percutaneous PFO closure for cryptogenic stroke in the setting of a systematic cardiac and neurological screening and a standardised follow-up protocol (2017) (4)
Coronavirus disease 2019-associated coronary endotheliitis and thrombotic microangiopathy causing cardiogenic shock: a case report (2022) (4)
Pressure curve measurements during transcatheter aortic valve implantation: a useful tool to assess the severity of aortic regurgitation. (2013) (4)
Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes. (2001) (4)
Multisite vascular disease in acute coronary syndromes: increased in-hospital mortality and no improvement over time (2020) (4)
Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines (2016) (4)
Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary (2019) (4)
[Post-myocardial infarction ventricular septal defect]. (2017) (4)
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk. (2022) (4)
Principles of Carotid Artery Stenting (2008) (3)
Minimizing Distal Embolization During Carotid Artery Stenting. (2019) (3)
Elevated Baseline CRP Levels Predict Death or MI in Diabetic Patients Undergoing Percutaneous Coronary Intervention (2001) (3)
The struggle of carotid artery stenting (2015) (3)
Cardiovascular Catheterization and Intervention : A Textbook of Coronary, Peripheral, and Structural Heart Disease, Second Edition (2017) (3)
Cryptogenic stroke with right-to-left shunt and no patent foramen ovale. (2014) (3)
Applicability of European Society of Cardiology guidelines according to gross national income (2022) (3)
Chronic total occlusions in non-infarct-related arteries. (2012) (3)
Carotid Artery Stenting: A Single Center “Real World” Experience (2012) (3)
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry (2021) (3)
Percutaneous intervention of saphenous vein grafts (2004) (3)
Determinants of hospital length of stay after transcatheter aortic valve implantation with self-expanding prostheses: a prospective, single centre observational study. (2019) (3)
Exclusion of a coronary aneurysm with a polyurethane-covered stent. (2019) (3)
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention (2018) (3)
Proving the Safety of Carotid Artery Stenting: Now or Never (2012) (3)
[Endovascular treatment of below the knee arteries in critical limb ischemia]. (2010) (3)
The European Society of Cardiology - A Digital Educator (2021) (3)
Massive aortic regurgitation following paravalvular balloon valvuloplasty of an edwards sapien valve treated by emergent corevalve implantation: Never cross a transcatheter aortic valve without a pigtail (2013) (3)
Outcomes and regional differences in practice in a worldwide coronary stent registry (2022) (3)
Tools & techniques: aortoiliac and common femoral endovascular interventions. (2010) (3)
Transcatheter Aortic Valve Implantation in a 99‐Year‐Old Woman: Are We Going Too Far? (2012) (3)
[New techniques for the endovascular treatment of peripheral arterial disease]. (2011) (3)
How should I treat a complex left subclavian artery stenosis involving the vertebral artery in a patient with subclavian steal syndrome and left internal mammary artery bypass graft? (2015) (3)
Rapid progression of left main coronary disease causing acute coronary syndrome. (2011) (2)
Adventitial hematoma triggering coronary spasm during percutaneous coronary intervention. (2001) (2)
Influence of plaque volume on hemodynamic response and stress hormone release in patients undergoing carotid artery stenting. (2012) (2)
PROGNOSTIC SIGNIFICANCE OF SYNTAX SCORE II IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS INTERVENTION (2015) (2)
Percutaneous noncoronary interventions during continuous mechanical chest compression with the LUCAS-2 device. (2013) (2)
Combined complex PCI and TAVI procedure in a 94-year-old man: Two more 4000-meter summits to go (2013) (2)
Young woman with cardiac arrest due to spontaneous coronary artery dissection (2020) (2)
Coronary thrombectomy by retrieval of an open emboli-protection filter device (2008) (2)
Peripheral interventions: how long will they remain a missed opportunity? (2011) (2)
[Acute coronary syndrome: guidelines and geriatrics specificity]. (2009) (2)
[Management of carotid artery stenosis]. (2017) (2)
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates. (2019) (2)
Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation (2020) (2)
Impact of cardiac rehabilitation participation on patient-reported lifestyle changes one year after myocardial infarction (2019) (2)
Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST (2021) (2)
What is new in the 2020 ESC NSTE‐ACS guidelines (2020) (2)
Images in cardiology. No reflow during carotid stenting. (2006) (2)
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS (2018) (2)
Superficial femoral artery occlusion: nitinol stents achieve flow and reduce the need for medications better than balloon angioplasty alone. (2004) (2)
Carotid artery stenting (2003) (2)
Platelet glycoprotein IIb/IIIa antagonists are beneficial in patients with acute coronary syndromes who undergo in-hospital coronary artery bypass surgery (2003) (2)
Five-year outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with acute coronary syndrome: A subgroup analysis of the BIOSCIENCE trial. (2021) (2)
Gender-related mortality trends among diabetic patients with STEMI: insights from a nationwide registry 1997- 2010 (2013) (2)
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way (2020) (2)
Temporal trends in in-hospital complications of acute coronary syndromes: Insights from the nationwide AMIS Plus registry. (2020) (2)
Discordance in the diagnostic assessment of vulnerable plaques between radiofrequency intravascular ultrasound versus optical coherence tomography among patients with acute myocardial infarction: insights from the IBIS-4 study (2021) (2)
Impact of Multisite artery disease on Clinical Outcomes After Percutaneous Coronary Intervention: An Analysis from the e-Ultimaster Registry. (2022) (1)
Post-operative Staphylococcus aureus infection of a superficial femoral artery stent. (2013) (1)
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries (2020) (1)
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries]. (2012) (1)
A new rapid ecarin clotting time assay but not activated clotting time strongly correlates with bivalirudin concentration: a percutaneous coronary intervention study (2002) (1)
[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?]. (2010) (1)
Carotid artery stenting versus endarterectomy for carotid stenosis (2010) (1)
Abstract 15233: Impact of Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Propensity Score-Matched Analysis of the Amis-Plus Registry (2014) (1)
Coronary stent thrombosis in acute coronary syndromes (2018) (1)
[Role of endovascular therapy in the management of patients with lower extremity atherosclerotic disease according to new European guidelines]. (2012) (1)
Newer Generation Drug-Eluting Stents for Revascularization of Chronic Total Occlusions. (2017) (1)
[Clopidogrel and its salts: any clnical implication?]. (2010) (1)
Percutaneous coronary intervention under temporary peripheral veno-arterial extracorporeal membrane oxygenation. (2020) (1)
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE). (2021) (1)
Intravascular lithotripsy to treat an ostial left main coronary artery stenosis due to porcelain aorta in a patient with congenital high-density lipoprotein deficiency (2020) (1)
Digital transformation of major scientific meetings induced by the COVID-19 pandemic: insights from the ESC 2020 annual congress (2021) (1)
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures. (2016) (1)
[Transcatheter aortic valve implantations in 2011: the interventional cardiologist]. (2011) (1)
Emerging Concepts and Designing Effectiveness Research in the Process of Care of Patients Hospitalized with an Uncomplicated Acute CoronarySyndrome (2013) (1)
Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018. (2019) (1)
[Carotid stenting: an alternative to surgery?]. (2009) (1)
Background, fundamental concepts, and scientific evidence of the high-sensitivity cardiac troponin 0h/1h-algorithm for early rule-out or rule-in of acute myocardial infarction (2016) (1)
[Mechanical complications of myocardial infarction]. (2011) (1)
TCT-481 Comparison of newer generation drug-eluting stents with bare metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of EXAMINATION and COMFORTABLE AMI trials (2012) (1)
[Percutaneous left atrial appendage closure: an alternative in patients with atrial fibrillation and high bleeding risk?]. (2012) (1)
The impact of the COVID-19 pandemic on the management and outcomes of STEMI patients in Switzerland (2021) (1)
Prognostic value of intracoronary imaging-derived measures for non-infarct related vessel revascularization throughout 7 years among patients with ST-elevation myocardial infarction (2020) (1)
Diabetes and the heart: a complex interaction. (2009) (1)
Complex percutaneous coronary interventions by transradial approach using sheathless guiding catheters (2012) (1)
[Highlights from the 2015 ESC NSTE-ACS Guidelines]. (2016) (1)
Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial. (2021) (1)
Coronary risk assessment with computed tomography in asymptomatic individuals (2013) (1)
A giant coronary artery aneurysm associated with multiple peripheral arterial aneurysms and an abdominal aortic aneurysm. (2018) (1)
Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes (2020) (1)
Delay between symptom onset and hospital admission in patients with ST-elevation myocardial infarction: different trends in men and women (2020) (1)
Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial (2023) (1)
Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification (2022) (1)
TCT-617 How Do Results from RCTs and Registries Differ? (2012) (0)
Regional differences in PCI practice and clinical outcomes among patients with diabetes mellitus enrolled in a contemporary world-wide registry (2020) (0)
Letter by Mueller and Roffi Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction". (2017) (0)
TCT-471 BIOVITESSE – Multicenter prospective First In Man study of a new polymer free drug-coated stent with ultrathin struts: One month optical coherence tomography results of Cohort 1 (2018) (0)
Commentary: The Long and Winding Road (2018) (0)
Unexpected Interrupted Inferior Vena Cava Diagnosed During Failed Transcatheter Left Atrial Appendage Closure. (2016) (0)
Peripheral arterial angiography (2010) (0)
[Treatment after drug-eluting stent placement]. (2007) (0)
Severe stenosis of a bovine jugular vein graft in pulmonary position. (2005) (0)
P1968Five-year outcomes in patients with diabetes mellitus treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents (2019) (0)
Recanalization of Acute Left Internal Mammary Artery Graft Failure by Percutaneous Coronary Intervention (2017) (0)
Sex inequities in the performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndromes: a multinational observational study in contemporary cohorts from four European countries (2022) (0)
Sex differences in acute coronary syndromes: a never ending same old story or sign for improvement (2022) (0)
and carotid artery stenting Current evidence for carotid endarterectomy (2010) (0)
Specific diseases: stroke (2018) (0)
P4391Cardiovascular risk factor trends over two decades in patients presenting with acute myocardial infarction: a failure of smoking control, especially in women (2019) (0)
Iconography : Cryptogenic stroke with right-to-left shunt and no patent foramen ovale (2012) (0)
a new treatment option in cases of massive pulmonary embolism (2013) (0)
Curing by Burning: What to expect from renal denervation in the treatment of arterial hypertension (2012) (0)
Clinical outcomes in STEMI patients undergoing percutaneous coronary interventions later than 48 hours after symptom onset. (2023) (0)
TCT-573 Following Biolimus-Eluting Stenting, No Excess in 3-Year MACE in Diabetic Patients not treated with Insulin (2015) (0)
Non-ST-Elevation Myocardial Infarction: Management (2014) (0)
ESC Congress 2019: a very special event for Switzerland (2019) (0)
PERIPHERAL DIAGNOSTIC CATHETERS (2010) (0)
Carotid artery stenting: still burdened by early trial results. (2022) (0)
TCT-262 Comparable low rates of MACE between patients with ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) patients in the 12-month follow-up of the e-BioMatrix registry (2013) (0)
Multiple silent postinfarction complications (2012) (0)
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT (2023) (0)
Percutaneous Retrieval of Foreign Bodies (2014) (0)
The Show is Over: time to start preparing the new one. (2010) (0)
[Cardiac surgery in the time of COVID19 - A narrative of three very unusual cases and lessons learned]. (2022) (0)
Scuba diving, acute left anterior descending artery occlusion and normal ECG (2013) (0)
Pooled Analysis of Five Randomized Clinical Trials Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts : A Lack of Benefit From Intravenous Platelet Glycoprotein IIb / IIIa Receptor Inhibition as (2002) (0)
Complications of PCI: stent loss, coronary perforation and aortic dissection (2010) (0)
TCT-216 Predictors Of Patient-Oriented And Device-Oriented Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention (2013) (0)
REVIEW ARTICLE Endovascular Stroke Treatment Today (2011) (0)
Left main stem thrombosis in a 37-year-old man (2011) (0)
381 In vivo validation of velocity profiles in coronary arteries- the shape factor is a variable (2003) (0)
Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction. (2022) (0)
Coronary thrombectomy by retrieval of an open emboli-protection filter device (2009) (0)
Predictors of adverse events complicating carotid artery stenting in the era of distal protection devices (2003) (0)
Controversies in cardiovascular medicine series Carotid artery stenting vs . endarterectomy (2009) (0)
P766The effect of endothelial shear stress on fibroatheroma progression: a serial intravascular ultrasound, optical coherence tomography and blood flow simulation study (2018) (0)
Percutaneous coronary intervention under temporary peripheral veno-arterial extracorporeal membrane oxygenation (2020) (0)
Medically-managed Patients With NonST-segment Elevation Acute Coronary Syndromes: An Ill-defined Entity. (2017) (0)
What a Congress! (2019) (0)
Anomalous Coronary Arteries (2010) (0)
Acute decrease in kidney function after acute coronary syndromes predicts future bleeding and cardiac death (2020) (0)
P1320Optical coherence tomography versus virtual histology intravascular ultrasound for the assessment of thin-cap fibroatheroma (2017) (0)
[Patent foramen ovale closure : update]. (2018) (0)
Platelet Inhibition in Percutaneous Coronary Interventions (2005) (0)
Percutaneous coronary intervention versus coronary-artery bypass grafting. (2009) (0)
[AVC: surgery or carotid stents?]. (2010) (0)
CORONARY PERFORATIONS Introduction (2010) (0)
Percutaneous Aortic Balloon Valvuloplasty and Intracardiac Adrenaline in Electromechanical Dissociation as Bridge to Transcatheter Aortic Valve Implantation (2015) (0)
1190 Basal and midventricular balloning: new patterns of transient left ventricular ballooning? (2006) (0)
Carotid and vertebral artery interventions (2010) (0)
[Role of percutaneous coronary intervention in diabetic patients]. (2013) (0)
Author`s Reply (2020) (0)
Quantitative flow ratio to predict non-target-vessel-related events at 5 years in STEMI patients undergoing angiography-guided revascularization (2020) (0)
Chapter 1. Acute Coronary Syndromes (2010) (0)
Improved outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery treated with combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition (2002) (0)
Age-Related Outcomes after Transcatheter Aortic Valve Implantation: Insights from the SwissTAVI Registry (2020) (0)
the AMIS Investigators (2018). Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clinical Research in Cardiology , 107 (4), 338-346. (2019) (0)
Correction: Carotid Artery Stenting: A Single Center “Real World” Experience (2012) (0)
Thromboembolic leg ischaemia as first manifestation of an unrecognised myocardial infarction (2000) (0)
826-2 Interleukin-6 but not C-reactive protein is elevated at the site of ruptured plaques in acute coronary syndromes (2004) (0)
P5542Relationship between smoker's paradox and p2y12 receptor inhibition therapy in patients with STEMI undergoing primary PCI (2017) (0)
Tips and tricks of the angiographic anatomy of the carotid arteries and vertebrobasilar system (2009) (0)
ANGIOGRAPHIC TECHNIQUE Arterial Access (2010) (0)
Influence of Various Percutaneous Coronary Interventional Devices on Postinterventional Luminal Shape and Plaque Surface Characteristics as Determined by Intravascular Ultrasound (2003) (0)
Recurrent myocardial infarction caused by peripartum left main spontaneous coronary artery dissection, extending to the left anterior descending artery and left circumflex artery. (2020) (0)
[The Heart and Brain -- a clinically significant situation relationship]. (2008) (0)
’ s response to reviews Title : Prognostic value of frailty in elderly patients with acute coronary syndrome : A systematic review and meta-analysis (2019) (0)
259 Validation of a new Doppler power-based method for invasive volumetric measurement of coronary blood flow and flow reserve in humans versus PET (2003) (0)
Coronary revascularization in diabetic patients. (2015) (0)
Introduction (2018) (0)
TCT-4 Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial Infarction (2013) (0)
What to expect from renal denervation in the treatment of arterial hypertension (2012) (0)
Distal emboli protection intervention in native coronary artery occlusion. (2003) (0)
Embolization to Two Different Vascular Territories in a Patient With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation (2020) (0)
Successful percutaneous mechanical thrombectomy of an Impella CP-related femoral artery thrombosis. (2021) (0)
Lack of improvement in ST segment resolution after the combination treatment of abciximab with reteplase compared to reteplase alone for acute myocardial infarction: results from the GUSTO V-RESTART substudy (2002) (0)
Carotid Artery Disease (2021) (0)
Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial. (2020) (0)
Impact of diabetes on acute coronary syndrome management (2004) (0)
Large-Scale CAS Registries (2010) (0)
Percutaneous Coronary Interventions for NSTEMI and Unstable Angina (2018) (0)
Antiplatelet therapy and oral anticoagulation following peripheral arterial bypass surgery (2004) (0)
Percutaneous stenting of a vertebral artery supplying the entire brain. (2001) (0)
[Antiplatelet agents and older patients: which drugs and what evidence?]. (2013) (0)
Valor pronóstico de las frecuencias cardiacas bajas en pacientes ingresados con infarto agudo de miocardio (2023) (0)
[Stable and asymptomatic coronary heart disease: a new paradign]. (2010) (0)
[Specificities of diabetes in acute coronary syndromes]. (2011) (0)
P3630Coronary angiography and percutaneous coronary intervention post implantation of a transcatheter aortic valve (2019) (0)
Tratamiento conservador en pacientes con síndrome coronario agudo sin elevación del ST: una entidad mal definida (2017) (0)
Predictive value of 60-minute ST segment resolution in electrocardiogram after lytic therapy in patients with acute myocardial infarction: results from the GUSTO V-RESTART study (2002) (0)
European Society of Cardiology Congress 2019 Together With the World Congress of Cardiology in Paris: The Scientific Chairs Give the Inside Track on Achieving Excellence and Engagement. (2019) (0)
Recurrent Vasospastic Myocardial Infarctions and Hand Necrosis. (2017) (0)
Utilización de un marcapasos explantado conectado a un electrodo clásico de fijación activa para estimulación ventricular temporal (2011) (0)
TCT-257 Frequency and clinical impact of prasugrel cessation after primary PCI in STEMI patients: a prospective cohort study (2015) (0)
[Paravalvular leak following surgical valve replacement: is there a role for percutaneous paravalvular leak reduction?]. (2010) (0)
Platypnoea-orthodeoxia syndrome: more than just a PFO (2014) (0)
Special conditions: acute coronary syndromes (2018) (0)
Collaterals and extent of myocardial injury in patients with acute coronary syndromes – an analysis of the prospective SPUM-ACS cohort (2022) (0)
Contents (2020) (0)
Measurement of Cardiac Output (2010) (0)
Diagnóstico inesperado de una interrupción de la vena cava inferior durante el fallo de un cierre percutáneo de la orejuela auricular izquierda (2016) (0)
Pentoxifylline and cilostazol for intermittent claudication (2004) (0)
056 Mutli-dimensional prevention program after acute coronary syndrome (ELIPS) (2010) (0)
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study and for the IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416) (2015) (0)
Prognostic value of low heart rates in patients admitted with acute myocardial infarction. (2023) (0)
[Interpretation of high-sensitivity troponin in patients with chronic kidney failure]. (2016) (0)
Emboli protection devices in cardiovascular medicine (2009) (0)
Effect of high-intensity statin therapy on atherosclerosis (IBIS-4): Manual versus automated methods of IVUS analysis. (2023) (0)
Acute myocardial infarction and work inability: insights from the AMIS Plus registry (2022) (0)
5-year outcomes in patients with acute coronary syndrome treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents (2020) (0)
Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry. (2022) (0)
Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry. (2023) (0)
Impact of Sex on Clinical Outcomes in Patients undergoing Complex Percutaneous Coronary Angioplasty (from the e-ULTIMASTER Study). (2022) (0)
Treatment and outcome of patients with acute myocardial infarction and chronic lung disease: insights from the nationwide AMIS Plus registry (2022) (0)
Age-related clinical and hemodynamic outcome following transcatheter aortic valve replacement: a swiss TAVI registry analysis (2020) (0)
Heavy drinking habits are associated with worse in-hospital outcomes in patients with acute coronary syndrome (2020) (0)
[Spontaneous coronary artery dissection : primum nihil nocere]. (2020) (0)
20-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalised in Switzerland. (2023) (0)
5918Influence of intravenous fentanyl versus morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI (2018) (0)
Acute decrease in kidney function after acute coronary syndromes predicts future bleeding and death (2020) (0)
Discrepancies Between IVUS and Angiography (2010) (0)
P5564Differences in presentation and clinical outcomes between patients with acute myocardial infarction and right or left bundle branch block (2018) (0)
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction (2021) (0)
Heart rate and mortality in myocardial infarction: incremental or bimodal correlation? (2022) (0)
Bleeding risk in patients hospitalized for non-ST-segment elevation acute coronary syndromes in Switzerland: performance of the CRUSADE score (2022) (0)
Ventricular Septal Rupture (2010) (0)
Long-term antiplatelet therapy in PVD (2004) (0)
Risk reduction strategies: coronary revascularization before non-cardiac surgery (2018) (0)
Image in Cardiology. Takayasu arteritis. (2003) (0)
Abstract 2601: Increased TLR-4+ Monocytes in Thrombi from the Site of Coronary Occlusion in Acute Coronary Syndromes - a Role for Innate Immunity in Acute Coronary Syndrome (2007) (0)
SoloPath® sheath for transfemoral transcatheter aortic valve replacement (2014) (0)
Dissection coronaire spontanéeâ: primum nihil nocere . (2020) (0)
Author`s Reply (2020) (0)
No reflow during carotid stenting (2005) (0)
Vessel Overlap, Foreshortening, and Ostial Lesions (2010) (0)
Left main coronary artery perforation during percutaneous coronary intervention in a patient with noninfectious aortitis. (2014) (0)
TCT-167 Percutaneous Coronary Intervention With Ultrathin-Strut Biodegradable Versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized Trials (2022) (0)
Coronary heart disease Myeloid-related protein 8 / 14 complex is released by monocytes and granulocytes at the site of coronary occlusion : a novel , early , and sensitive marker of acute coronary syndromes (2007) (0)
Medically–managed Patients With Non–ST-segment Elevation Acute Coronary Syndromes: An Ill-defined Entity Tratamiento conservador en pacientes con sı́ndrome coronario agudo sin elevación del ST: una entidad mal definida (2017) (0)
Adjunctive antithrombotic therapy for endovascular procedures (2004) (0)
Coeliac trunk stenting for mesenteric ischaemia (2013) (0)
Percutaneous treatment for pacemaker lead-related SVC syndrome (2002) (0)
Prognostic value of the blood lactate peak in patients with acute coronary syndrome under extracorporeal cardiopulmonary resuscitation. (2017) (0)
ESC CONGRESS 2020-the digital experience: expanding the reach of the society. (2021) (0)
Cocaine consumption and acute coronary syndromes: a cross sectional study from the Swiss registry AMIS Plus (2021) (0)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes Clinical Investigation and Reports (2001) (0)
Coronary perforations during percutaneous coronary interventions (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marco Roffi?

Marco Roffi is affiliated with the following schools:

Marco Roffi's Academic­Influence.com Rankings

Marco Roffi's Degrees

Similar Degrees You Can Earn

Why Is Marco Roffi Influential?

Marco Roffi's Published Works

Published Works

What Schools Are Affiliated With Marco Roffi?

Marco Roffi's AcademicInfluence.com Rankings